Docusign (DOCU) Research & Development (2017 - 2026)

Docusign (DOCU) has reported Research & Development for 10 consecutive years, with $314.0 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Research & Development rose 2.79% year-over-year to $314.0 million in Q3 2026; TTM through Jul 2026 was $1.2 billion, a 1.54% increase from a year earlier, with the FY2026 full-year figure at $1.2 billion, up 3.69% from the prior year.
• Research & Development was $314.0 million for Q3 2026 at Docusign, up from $296.2 million in the prior quarter.
• Over five years, Research & Development peaked at $323.6 million in Q3 2022 and troughed at $280.6 million in Q2 2023.
• A 5-year average of $299.2 million and a median of $299.4 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development soared 34.94% in 2022 and declined 8.88% in 2023, its largest moves.
• Over 5 years, Research & Development stood at $313.8 million in 2022, then dropped by 6.79% to $292.5 million in 2023, then declined by 0.64% to $290.6 million in 2024, then gained by 2.04% to $296.5 million in 2025, then rose by 5.88% to $314.0 million in 2026.
• The last three Research & Development figures came in at $314.0 million (Q3 2026), $296.2 million (Q2 2026), and $305.5 million (Q1 2026), per Business Quant data.